Predicting response after infliximab salvage in acute severe ulcerative colitis
Matthew C. Choy(The University of Melbourne), Peter De Cruz(The University of Melbourne), Graham Radford‐Smith(QIMR Berghofer Medical Research Institute), Daniel R. van Langenberg(Eastern Health), Finlay Macrae(The Royal Melbourne Hospital), Dean Seah(Austin Hospital), Chengyu Chen(Royal Brisbane and Women's Hospital), Yoon‐Kyo An(Mater Hospital), Gregory Moore(Monash Medical Centre), Miles Sparrow(Alfred Health), William Connell(St Vincent's Hospital Melbourne), Alexandra Gorelik(The University of Melbourne)
Cited by 51
Related Papers
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k
Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
|The Lancet|2015|779